John Burn talking at ECCO15-ESMO34 in Berlin about his international study showing that aspirin prevented the development of Hereditary Non-Polyposis Colon Cancer in people genetically at risk for the disease.[audio:https://www.audiomedica.com/podcasting/otbn/090924OTBNJohnBurnPODCAST.mp3]
You may also like...
Which High-Risk Prostate Cancers Need Multimodality Treatment? 18 Apr, 2017 Niraparib Quadruples Progression Free Survival in Platinum-Sensitive Ovarian Cancer 21 Oct, 2016 Chronic myeloid leukaemia: third generation TKI, ponatinib, succeeds against the T 315 I mutation 18 Dec, 2012 Two-step immunotherapy brings promise in advanced ovarian cancer 8 Apr, 2013
- Previous story For Early Breast Cancer, Switch to Aromatase Inhibitor after Tamoxifen Extends Survival
- Next story Aromatase Inhibitor Better than Tamoxifen for Initial Adjuvant Therapy for HR- Positive Breast Cancer, But Compliance an Issue!
- Ultrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
- First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
- Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
- Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
- MMR vaccine’s non-specific effects: adherence to recommended vaccination schedules protects children against non-vaccination-specific infections tooFebruary 28, 2014